IP36-09: Evaluating the Surrogacy of Intermediate Clinical Endpoints for Overall Survival after Perioperative Treatment in Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy

IP36-09: Evaluating the Surrogacy of Intermediate Clinical Endpoints for Overall Survival after Perioperative Treatment in Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy

Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!